Stefan, Norbert
Hartleb, Marek
Popovic, Branko
Varona, Rafael
Funding for this research was provided by:
Sanofi
Universitätsklinikum Tübingen
Article History
Received: 15 December 2023
Accepted: 29 May 2024
First Online: 11 June 2024
Declarations
:
: This study was approved by the Ethics Committee at the Medical Faculty of the Eberhard Karls University and at the University Hospital Tübingen, Germany (Project Number: 251/2022AMG1). The trial is being performed in accordance with the ethical principles that have their origin in the Declaration of Helsinki, ICH GCP, and all applicable regulations. Written consent is obtained from each participant prior to the collection of data.
: Not applicable.
: NS has received speaking honoraria from Sanofi. MH has received lecture honoraria from Sanofi. BP and RV are employees of Sanofi and may hold shares or stock options in the company.